Long Yu
Impact in
- Cancer Research top 0.5%
- Cancer-related molecular mechanisms research
- Cell Biology top 0.5%
- Cellular Mechanics and Interactions
- Microtubule and mitosis dynamics
Papers in
-
- Ubiquitin and proteasome pathways 38
- RNA modifications and cancer 27
- RNA Research and Splicing 24
- Signaling Pathways in Disease 15
- Oncology 99
- Cancer-related Molecular Pathways 40
- Peptidase Inhibition and Analysis 17
- Co-authors
- Peter N. Devreotes (15 shared papers)Bo Wan (35 shared papers)Zhan Xiao (1 shared paper)Yihong Yao (1 shared paper)Chenji Wang (24 shared papers)Lihuan Cao (18 shared papers)Xianmei Yang (22 shared papers)Pingzhao Zhang (26 shared papers)
- Journals
- Molecular Biology Reports (24 papers)Biochemical and Biophysical Research Communications (21 papers)PLoS ONE (11 papers)Breast Cancer Research and Treatment (9 papers)Cancer Letters (7 papers)
- Partner nations
- ChinaUnited StatesSouth Korea
In The Last Decade
Long Yu
361 papers receiving 9.8k citations
Long Yu's Hit Papers
Peers
Comparison fields: 5 of 154
- Cancer Research 1.5k
- Cell Biology 1.7k
- Molecular Biology 5.4k
- Oncology 1.6k
- Immunology and Allergy 231
Countries citing papers authored by Long Yu
This map shows the geographic impact of Long Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Long Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Long Yu more than expected).
Fields of papers citing papers by Long Yu
This network shows the impact of papers produced by Long Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Long Yu. The network helps show where Long Yu may publish in the future.
Co-authors
The 25 scholars most cited alongside Long Yu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 370 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1999 | 414 | |
| 2 | Tumor-derived lactate promotes resistance to bevacizumab treatment by facilitating autophagy enhancer protein RUBCNL expression through histone H3 lysine 18 lactylation (H3K18la) in colorectal cancer Hit paper breakdown → | 2023 | 294 |
| 3 | 2000 | 240 | |
| 4 | 2003 | 240 | |
| 5 | 2014 | 196 | |
| 6 | 2014 | 185 | |
| 7 | 2009 | 162 | |
| 8 | 2005 | 153 | |
| 9 | 2004 | 142 | |
| 10 | 2014 | 112 | |
| 11 | 1997 | 111 | |
| 12 | 2010 | 104 | |
| 13 | 2005 | 102 | |
| 14 | 2007 | 99 | |
| 15 | 2010 | 99 | |
| 16 | 2013 | 93 | |
| 17 | 2001 | 90 | |
| 18 | 2007 | 88 | |
| 19 | 2023 | 85 | |
| 20 | 2012 | 83 |
About Long Yu
Long Yu is a scholar working on Molecular Biology, Oncology, Cell Biology, Cancer Research and Epidemiology, having authored 370 papers that have together received 9.9k indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (40 papers), Ubiquitin and proteasome pathways (38 papers), Microtubule and mitosis dynamics (31 papers), RNA modifications and cancer (27 papers), RNA Research and Splicing (24 papers), Cancer, Hypoxia, and Metabolism (20 papers), Peptidase Inhibition and Analysis (17 papers) and Signaling Pathways in Disease (15 papers). The work is most often cited by research in Cancer Research (1.5k citations), Cell Biology (1.7k citations), Molecular Biology (5.4k citations), Oncology (1.6k citations) and Immunology and Allergy (231 citations). Long Yu has collaborated with scholars based in China, United States and South Korea. Frequent co-authors include Peter N. Devreotes, Bo Wan, Zhan Xiao, Yihong Yao, Chenji Wang, Lihuan Cao, Xianmei Yang, Pingzhao Zhang, Hexige Saiyin and Jiaxue Wu. Their work appears in journals such as Molecular Biology Reports, Biochemical and Biophysical Research Communications, PLoS ONE, Breast Cancer Research and Treatment and Cancer Letters.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.